Omron 2003 Annual Report Download - page 17

Download and view the complete annual report

Please find page 17 of the 2003 Omron annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 58

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58

Mesh-Type Nebulizer
NE-U22
The world’s smallest and lightest
pocket-sized nebulizer, this unit
allows inhalation at any angle.
Blood Pressure Monitor
HEM-637IT
The first in Japan with a guide for
placement on the arm when
measuring, this monitor allows
daily management of blood
pressure data on a personal
computer.
Massage Chair Pisu
HM-601
This low-priced, comfortable
reclining chair incorporates a
massage unit that gives a full-
fledged massage.
➤ Business Overview
Healthcare Company (HCB) sales were buoyed by a moderate recovery in consumption in the early part of the fiscal year.
However, consumption slowed toward the end of the period. As a result, HCB sales increased 4.2 percent year-on-year to
¥42.3 billion.
Blood pressure monitors, thermometers and nebulizers, the core products of this division, sold well, and sales of a new
compact, low-cost massage chair expanded steadily in a brisk market. However, sales of products in other categories such
as electronic pulse massagers and pedometers declined.
By region, although sales in Japan were unchanged from the previous fiscal year, overseas sales grew strongly. Sales
increased substantially in the Asia/Oceania region, centered on Australia, and in China, where HCB expanded sales offices
and strengthened user support functions.
➤➤ Strategies and Outlook
HCB will work to expand its business by aggressively introducing new products, as well as strengthening overseas sales
channels and raising the power of its brands by marketing products that meet local market needs. Additionally, monitoring
lifestyle-related diseases is a core business domain, and HCB will develop hardware and create services in this new field.
HCB will also create a new business model that generates growth by supporting the prevention of lifestyle-related diseases.
Healthcare Company
Annual Report 2003 • 15